Loading company…
Oncodesign Services provides drug discovery, pharmacology, and preclinical research services.
Oncodesign Services conducts research and development for pharmaceutical companies, biotech firms, public research institutions, and investors. Its services include drug discovery, pharmacology, metabolism and pharmacokinetics studies, biomarkers, and biobanking. Founded in 1995 by CEO Dr. Philippe Genne, the company is based in Dijon, France. In June 2022, Edmond de Rothschild Private Equity (France) and company management acquired a 61.58% stake for USD 14.41 per share.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in